Investors see 2022 as a 'turning point' in GP-LP relations - AVCJ Forum
The private equity industry has undergone a profound shift as under-allocations have become over-allocations, fundraising and deployment have slowed, and the dynamic between GP and LPs has changed, the AVCJ Private Equity & Venture Forum heard.
“We will look back at 2022 as a turning point. We witnessed central banks rattle the markets by engaging in the most aggressive interest rate increases in decades,” said Ivan Vercoutere, managing partner...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.